Aims and Scope
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001.
Key Metrics
9.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.005 - 0.01
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
101
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q1
Pharmacology
SJR
- Q1 Pharmacology
- Q1 Drug Discovery
- Q1 Molecular Medicine
- Q1 Clinical Biochemistry
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.33
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
20%
4 to 6 months
58%
7 to 9 months
15%
Above 9 months
7%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Cancer
- Oxidative stress
- Sepsis
- Lung cancer
- Pathophysiology
- Tumor microenvironment
- Nrf2 pathway
- Guanylate cyclase
- Glioblastoma
- Central nervous system
- Alzheimer's disease
- Immune checkpoint
- Treatment options
- Obstructive sleep apnea
- Dysbiosis
- Pancreatic cancer
- Drug discovery
- Rheumatoid arthritis
- Immunotherapy
- Tam receptors
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1997 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Expert Opinion on Therapeutic Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
MiR-181a: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potential
- 8 Dec 24
- Expert Opinion on Therapeutic Targets
-
Full paper
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data
- 6 Dec 24
- Expert Opinion on Therapeutic Targets
-
Full paper
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets
- 1 Dec 24
- Expert Opinion on Therapeutic Targets
-
Full paper
FOXC1 and retinopathy: targeting molecular mechanisms in retinal blood vessel growth
- 21 Nov 24
- Expert Opinion on Therapeutic Targets
-
Full paper
ULK1 as a therapeutic target in kidney diseases: Current perspective
- 13 Nov 24
- Expert Opinion on Therapeutic Targets
-
Full paper
Immunotherapies in breast cancer: harnessing the cancer immunity cycle
- 11 Nov 24
- Expert Opinion on Therapeutic Targets
Scite analysis
Powered by scite_
2.5k articles received 62.6k citations see all
- 1,228 Supporting
- 60,393 Mentioning
- 89 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 8 Corrections
- 8 Errata
- 0 Expression of Concern
FAQs
How long has Expert Opinion on Therapeutic Targets been actively publishing?
Expert Opinion on Therapeutic Targets has been in operation since 1997 till date.
What is the publishing frequency of Expert Opinion on Therapeutic Targets ?
Expert Opinion on Therapeutic Targets published with a Monthly frequency.
How many articles did Expert Opinion on Therapeutic Targets publish last years ?
In 2023, Expert Opinion on Therapeutic Targets published 102 articles.
What is the eISSN & pISSN for Expert Opinion on Therapeutic Targets ?
For Expert Opinion on Therapeutic Targets,eISSN is 1744-7631 and pISSN is1472-8222.
What is Citescore for Expert Opinion on Therapeutic Targets ?
Citescore for Expert Opinion on Therapeutic Targets is 9.8.
What is H index for Expert Opinion on Therapeutic Targets ?
H index for Expert Opinion on Therapeutic Targets is 101.
What is SNIP score for Expert Opinion on Therapeutic Targets ?
SNIP score for Expert Opinion on Therapeutic Targets is 1.33.
What is the SJR for Expert Opinion on Therapeutic Targets ?
SJR for Expert Opinion on Therapeutic Targets is Q1.
Who is the publisher of Expert Opinion on Therapeutic Targets ?
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Therapeutic Targets.